6 research outputs found
Recommended from our members
Modular decomposition of the NOR-TSUM multiple-valued PLA
A method for designing PLA-based combinational circuits by modular decomposition is presented. Main subjects are 1) Specific properties of TSUM operator, 2) MIN-TSUM and NOR-TSUM expansions with respect to the bound set, X1 of variables, 3) Realization of functions by multiple-valued PLA-based combinational circuits, 4) Comparison with other methods. Experimental investigations show that the size of suggested combinational circuit is the same as the size of multiple-valued PLA implementing a multiple-valued logic function with large number of variables
The synthesis method of electronic circuits on PLA using evolutionary algorithms
Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄Π»Π°Π³Π°Π΅ΡΡΡ Π°Π»Π³ΠΎΡΠΈΡΠΌ ΠΌΠ΅ΡΠΎΠ΄Π° ΡΠΈΠ½ΡΠ΅Π·Π° Π΄ΠΈΡΠΊΡΠ΅ΡΠ½ΡΡ
ΡΡ
Π΅ΠΌ Π½Π° ΠΠΠ Ρ ΠΏΠΎΠΌΠΎΡΡΡ
ΡΠ²ΠΎΠ»ΡΡΠΈΠΎΠ½Π½ΡΡ
ΠΏΡΠΈΠ½ΡΠΈΠΏΠΎΠ². ΠΡΠ΅Π΄Π»Π°Π³Π°Π΅ΠΌΡΠΉ ΠΌΠ΅ΡΠΎΠ΄ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΡΡ ΠΏΡΠΈ ΠΏΡΠΎΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ Π±Π»ΠΎΠΊΠ°
ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ SpO2 (Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ ΠΊΠΈΡΠ»ΠΎΡΠΎΠ΄ΠΎΠΌ) ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠ³ΠΎ ΡΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΠΎΠ³ΠΎ
ΠΏΡΠΈΠ±ΠΎΡΠ°. ΠΡΠΈΠ²Π΅Π΄Π΅Π½Ρ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ
Development of electronic circuits using evolutionary computation principles
Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄Π»Π°Π³Π°Π΅ΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°ΡΡ ΡΠ²ΠΎΠ»ΡΡΠΈΠΎΠ½Π½ΡΠ΅ ΠΏΡΠΈΠ½ΡΠΈΠΏΡ ΠΏΡΠΈ ΠΏΡΠΎΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ Π΄ΠΈΡΠΊΡΠ΅ΡΠ½ΡΡ
ΡΡ
Π΅ΠΌ. ΠΠ΅ΡΠΎΠ΄ ΡΠ²ΠΎΠ»ΡΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ ΠΏΡΠΈ ΠΏΡΠΎΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΠΈΠ·Π΄Π΅Π»ΠΈΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΡΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΠΎΠΉ ΡΠ΅Ρ
Π½ΠΈΠΊΠΈ, Π² ΡΠ°ΡΡΠ½ΠΎΡΡΠΈ, ΡΠΈΠ½ΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π½ Π±Π»ΠΎΠΊ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ SpO2
PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including dabigatran etexilate, in the stroke prevention in patients with atrial fibrillation are considered. Factors that influence the choice of dabigatran dose in different individuals are discussed. Dabigatran treatment in special conditions is considered: during stroke development; in electrical or pharmacological cardioversion; in invasive or surgical procedures; during bleeding. Possible organizational system of thromboembolic events prevention in patients with atrial fibrillation is presented